{"database": "lobbying", "table": "lobbying_activities", "rows": [[624211, "534b1c2b-f639-45b9-aa65-1f652144c461", "Q2", "AMERICAN CAPITOL GROUP", 305852, "DISPENSING SOLUTIONS INC", 2008, "second_quarter", "PHA", "Drug Improtation, Pharmacy, Counterfiet Drugs, HR 5839, The Safeguarding American's Pharmaceuticals Act", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2008-07-09T17:07:15-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["624211"], "units": {}, "query_ms": 60.33015693537891, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}